Seqirus UK

Seqirus UK is a leading global biotechnology company dedicated to the development and production of innovative vaccines. Established as a part of the CSL Limited group, Seqirus focuses on addressing public health needs through its extensive portfolio of vaccines.

The company operates with a strong commitment to research and development, investing significantly in new technologies and methodologies to enhance vaccine efficacy and safety. With a robust pipeline of products, Seqirus aims to protect individuals and communities from infectious diseases.

Core Activities:

• Vaccine Development: Seqirus is involved in the research and development of vaccines for various infectious diseases, including influenza and other viral infections.
• Manufacturing: The company boasts state-of-the-art manufacturing facilities that adhere to the highest quality standards, ensuring the production of safe and effective vaccines.
• Public Health Initiatives: Seqirus collaborates with health authorities and organizations to promote vaccination programs and improve public health outcomes.

Seqirus UK is committed to sustainability and ethical practices, striving to minimize its environmental impact while maximizing health benefits. The company’s vision is to be at the forefront of vaccine innovation, contributing to a healthier future for all.

With a dedicated team of professionals, Seqirus fosters a culture of collaboration and excellence, driving advancements in immunization and disease prevention. The company’s mission is to save lives and protect communities through the power of vaccination.